美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SpyGlass Pharma, Inc.

20.49

-0.3900-1.87%

盤後：20.490.00000.00%19:34 EDT

成交量：10.38萬

成交額：217.95萬

市值：6.83億

市盈率：-15.27

高：21.80

開：21.80

低：20.36

收：20.88

52周最高：32.44

52周最低：17.06

股本：3,331.74萬

流通股本：1,078.13萬

量比：1.06

換手率：0.96%

股息：- -

股息率：- -

每股收益(TTM):-1.3420

每股收益(LYR):-17.9825

淨資產收益率：-67.71%

總資產收益率：-37.23%

市淨率：2.73

市盈率(LYR):-1.14

資料載入中...

總覽公司新聞公告

SpyGlass Pharma創新性Bim-Iol系統公佈12個月I/II期試驗積極頂線結果

旗艦企業 Generate Biomedicines 希望在美國 IPO 中獲得 22 億美元估值

異動解讀 | SpyGlass Pharma納斯達克IPO首日開盤價翻倍，盤中大漲50%

BUZZ-SpyGlass 在納斯達克首次公開募股 1.5 億美元后有望高開

美股異動 | SpyGlass Pharma(SGP.US)登陸美股市場開盤暴漲超43%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SGP/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SGP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGP\",,,,,undefined,":{"symbol":"SGP","market":"US","secType":"STK","nameCN":"SpyGlass Pharma, Inc.","latestPrice":20.49,"timestamp":1784923200000,"preClose":20.88,"halted":0,"volume":103818,"hourTrading":{"tag":"盘后","latestPrice":20.49,"preClose":20.49,"latestTime":"19:34 EDT","volume":1089,"amount":22312.81,"timestamp":1784936050610,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.01867816091954026,"floatShares":10781300,"shares":33317414,"eps":-1.342,"marketStatus":"休市中","change":-0.39,"latestTime":"07-24 16:00:00 EDT","open":21.8,"high":21.8,"low":20.36,"amount":2179477.020864,"amplitude":0.068966,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.342,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"listingDate":1770354000000,"exchange":"NASDAQ","adjPreClose":20.88,"postHourTrading":{"tag":"盘后","latestPrice":20.49,"preClose":20.49,"latestTime":"19:34 EDT","volume":1089,"amount":22312.81,"timestamp":1784936050610,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0643327834520513},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGP\",,,,,undefined,":{"symbol":"SGP","floatShares":10781300,"roa":"-37.23%","roe":"-67.71%","lyrEps":-17.982467,"volumeRatio":1.0643327834520513,"shares":33317414,"dividePrice":0,"high":21.8,"amplitude":0.068966,"preClose":20.88,"low":20.36,"week52Low":17.06,"pbRate":"2.73","week52High":32.44,"institutionHeld":0,"latestPrice":20.49,"eps":-1.342,"divideRate":0,"volume":103818,"delay":0,"ttmEps":-1.342,"open":21.8,"prevYearClose":16,"prevWeekClose":19.77,"prevMonthClose":22.26,"prevQuarterClose":22.26,"fiveDayClose":19.77,"twentyDayClose":18.81,"sixtyDayClose":23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-14","symbol":"SGP","fiscalQuarterEnding":"2026/03","expectedEps":-0.67,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.69},{"market":"US","date":"2026-03-26","symbol":"SGP","fiscalQuarterEnding":"2025/12","expectedEps":-6.61,"name":null,"time":"盤後","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-5.72}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.8,"buy":0.2,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.8,"analysts":5,"updateTime":1774670400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SGP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SGP","date":"2026-07-24","current":-15.268256,"percent":0.6625,"low":-21.652266,"twenty":-20.01284,"median":-16.428664,"eighty":-15.247112,"high":-14.017506,"avg":-17.316603,"sd":2.310642,"marketCap":698088452},"quantilePoints":[{"date":"2026-04-02","current":-20.423828,"twenty":-20.915203,"median":-19.976743,"eighty":-19.275615,"marketCap":814277598},{"date":"2026-04-10","current":-17.791054,"twenty":-19.887327,"median":-18.894548,"eighty":-18.2941,"marketCap":709311539},{"date":"2026-04-17","current":-20.985395,"twenty":-20.628232,"median":-19.259819,"eighty":-18.2941,"marketCap":836666721},{"date":"2026-04-24","current":-19.811622,"twenty":-20.628232,"median":-20.01284,"eighty":-18.750195,"marketCap":789869541},{"date":"2026-05-01","current":-19.233119,"twenty":-20.557806,"median":-19.76551,"eighty":-18.750195,"marketCap":766805217},{"date":"2026-05-08","current":-21.287223,"twenty":-20.628232,"median":-20.01284,"eighty":-18.869002,"marketCap":848700282},{"date":"2026-05-15","current":-20.348204,"twenty":-20.557806,"median":-19.991879,"eighty":-18.951807,"marketCap":811262538},{"date":"2026-05-22","current":-16.428664,"twenty":-20.542715,"median":-19.82839,"eighty":-18.248826,"marketCap":737055581},{"date":"2026-05-29","current":-16.634049,"twenty":-20.51924,"median":-19.719397,"eighty":-17.334564,"marketCap":663182890},{"date":"2026-06-05","current":-16.323837,"twenty":-20.485703,"median":-19.406541,"eighty":-16.365768,"marketCap":650815064},{"date":"2026-06-12","current":-15.166832,"twenty":-20.465581,"median":-18.98998,"eighty":-15.765344,"marketCap":604686416},{"date":"2026-06-18","current":-15.259057,"twenty":-20.45723,"median":-18.830682,"eighty":-15.591067,"marketCap":608363337},{"date":"2026-06-26","current":-14.017506,"twenty":-20.408703,"median":-18.172531,"eighty":-15.533886,"marketCap":628881407},{"date":"2026-07-02","current":-14.509349,"twenty":-20.348204,"median":-17.531147,"eighty":-15.527136,"marketCap":650947421},{"date":"2026-07-10","current":-14.956478,"twenty":-20.239211,"median":-16.634049,"eighty":-15.359666,"marketCap":671007434},{"date":"2026-07-17","current":-15.470677,"twenty":-20.105065,"median":-16.579363,"eighty":-15.259057,"marketCap":694076449},{"date":"2026-07-24","current":-15.560103,"twenty":-20.01284,"median":-16.428664,"eighty":-15.247112,"marketCap":698088452}],"updateTime":1785010555981},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SGP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1158394775","title":"SpyGlass Pharma創新性Bim-Iol系統公佈12個月I/II期試驗積極頂線結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1158394775","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158394775?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 20:01","pubTimestamp":1773057718,"startTime":"0","endTime":"0","summary":"SpyGlass Pharma公司宣布，其创新性Bim-Iol系统在为期12个月的I/II期临床试验中取得了积极的顶线结果。该数据展现了该系统在眼科治疗领域的应用潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613789435","title":"旗艦企業 Generate Biomedicines 希望在美國 IPO 中獲得 22 億美元估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2613789435","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613789435?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 19:54","pubTimestamp":1771847674,"startTime":"0","endTime":"0","summary":"更新版 3-旗舰企业 Generate Biomedicines 希望在美国 IPO 中获得 22 亿美元估值在第 3、6、7 段添加分析师评论Arasu Kannagi Basil路透2月23日 - 药物开发商Generate Biomedicines周一表示，该公司在美国首次公开募股的目标估值将高达21.7亿美元，从而进入上市步伐加快的生物技术市场。Aktis Oncology AKTS.O、Agomab Therapeutics AGMB.O、Veradermics MANE.N、Eikon Therapeutics EIKN.O和SpyGlass Pharma SGP.O今年已经登陆美国资本市场。\"Generate公司用于治疗严重哮喘的主要候选产品GB-0895正在进行后期试验。预计这项研究将于 2028 年上半年全部完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL4S3ZJ0Q2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","BK4552","LU0320765992.SGD","LU1868836914.USD","LU0234570918.USD","LU2750360997.AUD","AMGN","LU0096364046.USD","BK4566","BK4550","LU0122379950.USD","LU2089283258.USD","MRNA","MRNY","LU2471134796.USD","LU1162221912.USD","LU2111349929.HKD","BK4516","IE00BJJMRZ35.SGD","AGMB","IE00BKVL7J92.USD","LU1868836757.USD","MANE","LU0889565916.HKD","BK4127","LU2028103732.USD","LU1791807156.HKD","PIPR","LU1804176565.USD","GSX","LU2265009873.SGD","BK4532","LU0098860793.USD","LU0795875169.SGD","IE0004091025.USD","BK4534","LU0106261372.USD","LU2237443465.HKD","BK4139","LU2133065610.SGD","IE0009355771.USD","MRNX","LU1244550494.USD","SGP","EIKN","LU0251142724.SGD","LU2750360641.GBP","IE00B2B36J28.USD","AKTS","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173758808","title":"異動解讀 | SpyGlass Pharma納斯達克IPO首日開盤價翻倍，盤中大漲50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173758808","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173758808?lang=zh_tw&edition=fundamental","pubTime":"2026-02-07 01:29","pubTimestamp":1770398971,"startTime":"0","endTime":"0","summary":"生物制药公司SpyGlass Pharma, Inc.今日盘中股价大幅上涨，涨幅达到50.00%，引起了市场的广泛关注。消息面上，SpyGlass Pharma今日在纳斯达克成功完成首次公开募股，开盘价达到每股32美元，远高于其16美元的发行价。此次IPO以每股15至17美元的价格区间出售了约940万股股票，共融资1.5亿美元。SpyGlass Pharma成立于2019年，专注于为慢性眼病开发长效疗法的药物输送系统。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SGP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609898590","title":"BUZZ-SpyGlass 在納斯達克首次公開募股 1.5 億美元后有望高開","url":"https://stock-news.laohu8.com/highlight/detail?id=2609898590","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609898590?lang=zh_tw&edition=fundamental","pubTime":"2026-02-07 00:00","pubTimestamp":1770393659,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL4T3Z21PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","BK4207","LU0098860793.USD","BK4127","LU2360032135.SGD","BK4585","LU0072461881.USD","BK4566","LU2456880835.USD","LU2462157665.USD","LU0162691827.USD","LU1791807156.HKD","LU1506573853.SGD","LU1668664300.SGD","LU0130517989.USD","LU1244550577.SGD","MNSH","BK4559","LU2417539215.USD","LU0477156953.USD","LU0980610538.SGD","LU1244550494.USD","LU1201861249.SGD","LU0648001328.SGD","LU0320765646.SGD","LU1162221912.USD","LU1244550221.USD","BK4504","SGP","SF","BK4588","LU0052756011.USD","LU0310800965.SGD","BK4534","LU0106831901.USD","LU1366192091.USD","LU1267930227.SGD","LU0130102774.USD","LU2125154778.USD","LU2125154935.USD","LU0128525689.USD","LU0314106906.USD","LU0170899867.USD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609839513","title":"美股異動 | SpyGlass Pharma(SGP.US)登陸美股市場 開盤暴漲超43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609839513","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609839513?lang=zh_tw&edition=fundamental","pubTime":"2026-02-07 00:00","pubTimestamp":1770393633,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，SpyGlass Pharma(SGP.US)登陆美股市场，开盘股价暴涨超43%，报23美元，IPO价格为16美元。SpyGlass Pharma 是一家临床后期生物技术公司，专注于开发 用于慢性眼部疾病的持续药物输送系统，旨在通过更长效、可持续的治疗方案改善患者的视力和生活质量。其核心研发产品包括一种将药物输送垫与人工晶状体结合的系统，用于治疗像 开角型青光眼或眼压高 等慢性眼病。这类治疗目标是提高疗效和患者依从性，与传统每日滴眼药水相比有潜在优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["UWM","RWM","BK4535","MNQmain","BK4581","TNA","SRTY","BK4588","IWN","TWM","TZA","BK4550","SGP","BK4585","IWO","BK4534"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}